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sign of multiple myelomaV. Vucˇic´evic´-Boras*, I. Alajbeg, S. Brozovic, M. Mravak-StipeticDepartment of Oral Medicine, School of Dentistry, University of Zagreb,
Gunduliceva 5, 10 000 Zagreb, CroatiaReceived 20 October 2003; accepted 10 November 2003Summary A 79-year-old women was referred to our Department with burning
symptoms in the whole oral cavity together with clinically healthy appearence of the
oral mucosa. Hematological tests as well as bone marrow biopsy revealed diagnosis of
plasmocytoma. The aim of our case report was to underline the importance of
hematological screening in patients with burning mouth syndrome.c 2003 Published by Elsevier Ltd.Introduction
Multiple myeloma is a malignant disease that is
characterized by multifocal proliferation of atypi-
cal plasma cells and, in most patients, by the
presence in the serum of monoclonal gamma
globulins and/or their subunits, often referred to
as M or myeloma proteins. Secondary invasion of
skeletal tissue is one of the most important char-
acteristics of multiple myeloma, radiologically
evident in about 80% of the cases.1 It is most
commonly seen within the age range 60–70 and
men are affected more frequently. Neoplastic
proliferation originates primarily in hematopoietic
marrow manifesting in anemia, trombocytopenia
and neutropenia. In 12–15% of cases of multiple
myeloma the first manifestation of the disease
appears in the jaw bones and oral cavity.2 Oral
manifestations of multiple myeloma are clinical* Corresponding author. Tel.: +385-1-4802-124; fax: +385-1-
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doi:10.1016/j.ooe.2003.11.003features such as pain localized in the jaws or teeth,
paresthesias, swelling, soft tissue masses, mobility
of the teeth, migration of teeth, hemorrhage and
pathologic fracture due to osteolytic bone lesions.3
Malignant myeloma is recognized as a strong sus-
pect for unexplained chronic bone pain in all parts
of the skeleton. In the jaws such pain is usually
associated with the presence of osteolytic defects,
but atypical facial pain can result from sensory
neuropathia which occurs in multiple myeloma
even when the radiologic examination fails to re-
veal those bony defects.4Case report
A patient PM, 79 years old was referred to the
Department of Oral Medicine in Zagreb, Croatia
with symptoms of burning in the whole mouth,
especially severe on the anterior 2/3 of the tongue,
lasting for two months. The patient was not pre-
viously treated. Clinical examination showed
healthy appearence of the whole oral mucosa. In
the maxilla teeth 21, 22, 23 were present and the
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lous. The tooth 22 was asymptomatic, but X-ray
finding showed diffuse periapical radiolucency
around its root. No other bone defects could be
seen on X-ray finding. Regional lymph nodes were
not palpable. Detailed medical history revealed
surgical treatment of gallbladder in 1986, gastric
disturbances, and pancreatitis. Glucose tolerance
test was normal.The patient was sometimes suf-
fering from vertigo, headaches and she lost 14 kg
during past year due to a diarrhoeal episodes.
Prescribed medications included hypnotics-ben-
zodiazepin, three times daily (3 mg · 3 mg); ace-
tylsalic acid (100 mg once a day), and sometimes
alprazolam 1 mg once a day.
Candida culture from oral smears was positive.
The smear was taken and placed on Saboraud’s
agar for next 48 h on 37 C. Candidal infection was
treated with antifungals (2% miconasolum gel four
times a day during 10 days) and afterwards severe
burning was still persistent.
Routine blood screen tests were performed
and showed decreased red blood count being
3.07 · 1012/l (normal range 3.86–5.08 · 1012/l),
decreased hemoglobin levels 91 g/l (normal range
119–157 g/l), decreased hematocrit 0.272 l/l
(normal range 0.356–0.470 l/l), RDW was elevated
being 17.9 (normal range 14.6–16.5, individual
erythrocyte distribution); platelet count was
120 · 109/l (normal range 158–424 · 109/l) and
neutropenias was present 34.9% (normal range
44–72%). Erythrocyte sedimentation rate was ele-
vated and was 78 mm/h (normal range 5–28 mm/
h) according to Westergreen. Due to an abnormal
hematological finding she was reffered to hema-
tologist. A bone marrow biopsy specimen revealed
abnormal bone remodelling with reduced granulo-
cytopoesis albeit morphologically normal. Prolife-
ration of plasma cells was visible and they made
up 75%, which were partially pleomorphic. Both
findings were attributed to the diagnosis of plas-
macytoma. Bone marrow cytology showed normo-
cellular bone marrow but with erythrocyte,
granulocyte and platelet cells merged to the
periphery of the bone marrow, and atypical plasma
cells and plasmablasts presenting with 57% of all
cell types. Renal function was normal, although
urinalysis showed high protein content being more
than 1.0 g/l while the referent values are less than
0.05 g/l.
X-ray finding of the lungs as well as whole body
scan were normal. Electrophoresis of serum pro-
teins showed decreased albumin levels (38.1%,
normal 57–69%, normal alpha 1 being 2.7%
(2.0–4.0%), decreased alpha 23.1% (5.0–10.0%),
increased beta s 51.1% (8.0–12.0%) and decreasedgamma being 5.0% (13.0–22.0%). A monoclonal M
protein was detected on serum protein electro-
phoresis and on following immunelectrophoresis
was identified as IgG. IgG values were increased
(43.5 g/l, normal range 10.0–19.0 g/l) and IgA
values were decreased (0.1 g/l, normal range
1.1–3.8 g/l) as well as IgM values (0.1 g/l, normal
range 0.7–2.6 g/l). The diagnosis of IgG plasma-
cytoma was established by hematologist. One year
after the multiple myeloma was diagnosed, the
patient committed suicide.Discussion
Oral manifestations may be the first signs or
symptoms of multiple myeloma. Epstein et al.2
reviewed 783 cases from the literature and found
oral manifestations in 14% of patients with multiple
myeloma. Neuropathy is a dominant feature in only
10% of patients with multiple myeloma, and it
commonly preceeds the discovery of the blood
dyscrasia.5 Monoclonal anomalous protein may
have the property of antinerve antibody and be
able to cause the damage of axons and myelin in
nerves and subsequential sensory neuropathy.6 This
case report alert on the possible association of
burning mouth syndrome with multiple myeloma, a
finding not previously reported in the literature.
Previous reports of burning mouth syndrome as a
paraneoplastic syndrome were reported in patients
with malignant tumors of the pulmonary tract7 and
the acustic nerve neuroma.8 However, at this point
it cannot be discriminated whether burning mouth
syndrome is merely a coincidential finding, or it is a
result of the multiple myeloma itself. Neverthe-
less, it is our obligation to underline the impor-
tance of hematological screening, such as
complete blood count in patients with burning
mouth syndrome as a possible marker of blood
discrasias particularly malignant diseases of the
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